Form 4: Longeveron CMO Sells Shares for Tax Obligations

Longeveron Inc.'s Chief Medical Officer, Nataliya Agafonova, disposed of 11,883 Class A Common Stock shares to cover tax liabilities from a restricted stock unit vesting.

Summary

• Nataliya Agafonova, Chief Medical Officer of Longeveron Inc. (LGVN), reported a transaction involving Class A Common Stock.
• On October 1, 2025, 11,883 shares were disposed of at a price of $0.7424 per share.
• This disposition was a mandatory withholding of shares to satisfy tax obligations related to the vesting of a restricted stock unit (RSU) award.
• Following this transaction, Ms. Agafonova beneficially owns 226,814 shares of Class A Common Stock, which includes RSUs subject to future vesting.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While shares were disposed of, it was a non-discretionary sale for tax purposes following the vesting of an RSU award, which is a positive compensation event for the officer. It does not reflect a discretionary sale based on a negative outlook.

Positives

• The underlying event, the vesting of a restricted stock unit award, represents a form of compensation for the Chief Medical Officer, indicating continued alignment of executive incentives with company performance.

Negatives

• The transaction resulted in a reduction of 11,883 shares from the Chief Medical Officer's direct beneficial ownership, although this was a non-discretionary sale for tax purposes.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

The vesting of restricted stock units and subsequent withholding of shares for tax purposes is a standard and routine compensation practice for executives across various industries, reflecting a common mechanism for equity-based remuneration.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in management's confidence or company fundamentals.
• Employees: Reflects standard equity compensation practices for executives.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary insider transaction related to tax obligations from RSU vesting. It does not provide new information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Investors should 'hold' and await more comprehensive financial reports or strategic updates for investment decisions.

Keywords

Longeveron, LGVN, Form 4, Insider Transaction, Restricted Stock Unit, RSU, Tax Withholding, Beneficial Ownership, Chief Medical Officer